Estudo randomizado | Angioplastia pulmonar por balão vs. riociguat para tratamento de hipertensão pulmonar tromboembólica crônica não operável.

Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study – The Lancet Respiratory Medicine (link para o resumo – $ para o texto completo)

Comentário no Twitter

NEW—Pulmonary vascular resistance reduction was more pronounced with balloon pulmonary angioplasty (BPA) than with riociguat, but treatment-related SAEs were more common with BPA

Read the RACE trial from Xavier Jaïs & colleagues https://t.co/h9r3Qe2mCb

— The Lancet Respiratory Medicine (@LancetRespirMed) August 2, 2022